A fundamental understanding of the molecular mechanism governing osteoblast differentiation is essential for developing novel bone anabolic therapeutics. Physiological Notch signaling has emerged as a critical suppressive mechanism for osteoblast differentiation to ensure a proper pool of mesenchymal progenitors necessary for long-term bone homeostasis. Hyperactivation of NOTCH2 has recently been discover to cause Hajdu-Cheney syndrome (HCS) characterized by childhood osteoporosis, acroosteolysis and wormian bones. Where or not osteoblast or osteoclast defects are the primary cause for the disease has not been established. Moreover, an effective treatment for the disease is currently lacking. Elucidating the cellular basis for the disease and the relationship between NOTCH and other regulators of bone physiology will provide the basis for a rational design of therapeutics. I the current proposal, we test the hypothesis that suppression of osteoblast differentiation by hyperactive NOTCH2 is primarily responsible for HCS, and that stimulation of the bone anabolic WNT pathway may alleviate the bone defects associated with the disease. We further investigate the biochemical basis for the functional antagonism between NOTCH and WNT signaling. Overall, successful completion of this project is expected to provide novel mechanistic insights about the pathogenesis of HCS, and may open new avenues for effective treatments of the disease.
Hajdu-Cheney Syndrome is a rare autosomal dominant disease with early childhood onset. The disease is characterized by general osteoporosis, acroosteolysis and wormian bones. Recent discoveries have revealed that NOTCH2 hyperactivation mutations are responsible for the disease. This proposal is designed to understand the cellular and molecular mechanisms underlying the disease-causing effect of NOTCH2. Research results from this study may open new avenues for effective treatments of the disease.
|Karner, Courtney M; Long, Fanxin (2018) Glucose metabolism in bone. Bone 115:2-7|
|Lee, Seung-Yon; Abel, E Dale; Long, Fanxin (2018) Glucose metabolism induced by Bmp signaling is essential for murine skeletal development. Nat Commun 9:4831|
|Chen, Jianquan; Long, Fanxin (2018) mTOR signaling in skeletal development and disease. Bone Res 6:1|
|He, Guangxu; Shi, Yu; Lim, Joohyun et al. (2017) Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth. Bone Res 5:17016|
|Shi, Yu; He, Guangxu; Lee, Wen-Chih et al. (2017) Gli1 identifies osteogenic progenitors for bone formation and fracture repair. Nat Commun 8:2043|
|Lee, Wen-Chih; Guntur, Anyonya R; Long, Fanxin et al. (2017) Energy Metabolism of the Osteoblast: Implications for Osteoporosis. Endocr Rev 38:255-266|
|Karner, Courtney M; Lee, Seung-Yon; Long, Fanxin (2017) Bmp Induces Osteoblast Differentiation through both Smad4 and mTORC1 Signaling. Mol Cell Biol 37:|
|Lim, Joohyun; Burclaff, Joseph; He, Guangxu et al. (2017) Unintended targeting of Dmp1-Cre reveals a critical role for Bmpr1a signaling in the gastrointestinal mesenchyme of adult mice. Bone Res 5:16049|
|Karuppaiah, Kannan; Yu, Kai; Lim, Joohyun et al. (2016) FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth. Development 143:1811-22|
|Lim, Joohyun; Shi, Yu; Karner, Courtney M et al. (2016) Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse. Development 143:339-47|
Showing the most recent 10 out of 32 publications